DiviDrip · ALNY

ALNY — Alnylam Pharmaceuticals, Inc.

ALNY is Alnylam Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $266.11. Market cap: $35.61B. Capital Quality Rank: 95/100 — Market alpha.

Stock snapshot

Price$266.11
Market cap$35.61B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)95 / 100 · Market alpha
ROIC (TTM)283.6%
Revenue CAGR (3y)53.0%
Shareholder buyback yield-5.22%
Altman Z-score zoneSafe

About ALNY

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.

Listed2004Employees2.5KHQCambridge, MASectorHealthcareWebsitealnylam.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ALNY. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ALNY's current stock price?

ALNY (Alnylam Pharmaceuticals, Inc.) is currently trading at $266.11.

Does ALNY pay a dividend?

ALNY (Alnylam Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is ALNY's Capital Quality Rank?

ALNY has a Capital Quality Rank of 95/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ALNY in DiviDrip

Add ALNY to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow